Oppenheimer & Co’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Sell
25,641
-681
-3% -$44.8K 0.02% 729
2026
Q1
$1.87M Buy
26,322
+12,731
+94% +$1M 0.02% 613
2025
Q4
$1.11M Sell
13,591
-3,195
-19% -$249K 0.02% 760
2025
Q3
$1.26M Sell
16,786
-1,487
-8% -$111K 0.02% 784
2025
Q2
$1.35M Buy
18,273
+2,629
+17% +$183K 0.02% 723
2025
Q1
$1.26M Sell
15,644
-2,763
-15% -$237K 0.02% 706
2024
Q4
$1.44M Sell
18,407
-3,833
-17% -$326K 0.02% 655
2024
Q3
$2.09M Buy
22,240
+1,524
+7% +$128K 0.03% 543
2024
Q2
$1.61M Buy
20,716
+4,509
+28% +$368K 0.03% 599
2024
Q1
$1.47M Sell
16,207
-9,260
-36% -$770K 0.02% 610
2023
Q4
$1.97M Buy
25,467
+1,488
+6% +$104K 0.04% 498
2023
Q3
$1.63M Sell
23,979
-3,147
-12% -$229K 0.03% 518
2023
Q2
$2.2M Buy
27,126
+9,913
+58% +$791K 0.04% 452
2023
Q1
$1.41M Buy
+17,213
New +$1.23M 0.03% 565

Other funds holding GEHC

Oppenheimer & Co's GEHC Position: Q2 2026 in Review

Oppenheimer & Co reduced its GE HealthCare (GEHC) stake by 2.6% in Q2 2026, selling an estimated $44.8K and leaving 25,641 shares worth $1.64M. The position accounts for 0.02% of the portfolio, ranked #729.

Oppenheimer & Co first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.2M in Q2 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Oppenheimer & Co held 25,641 shares of GE HealthCare worth $1.64M as of Q2 2026.
  • Oppenheimer & Co sold 681 GE HealthCare shares in Q2 2026, an estimated $44.8K.
  • GE HealthCare made up 0.02% of Oppenheimer & Co's portfolio in Q2 2026, its #729 holding.
  • Oppenheimer & Co first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Oppenheimer & Co's GE HealthCare position peaked at $2.2M in Q2 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.